Supriya Lifescience Limited has filed its latest results with the exchange
In short
On June 30, 2026, the NSE sought clarification from Supriya Lifescience Limited for the quarter ended that date with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the company responded by enclosing its reply. No figures, breakdowns, scheme names or deadlines are given in the text. In simple terms, the exchange asked the company to explain its quarterly results disclosure requirements, and the company sent back a clarification. No closing date or validity period is stated.
Why it matters
Quarterly or annual numbers are now filed — worth checking revenue, profit and margin against the same quarter last year, not just the previous one. This brief was written from the filing itself: at the time of writing, no publisher in our feed had covered it.